Similarly, in the GSE44104 dataset, SPAG5 mRNA expression was higher in malignant ovarian cancer than that in ovarian tumors with low malignant potential (LMP) (P < 0.001, Figure 1F). This evidence concerns the gene SPAG5 and ovarian neoplasm.